WASHINGTON, DC – The Board of Pharmacy Specialties (BPS), the premier post-licensure certification agency worldwide, announced that Compounded Sterile Preparations (CSP) Pharmacy has been approved as its twelfth specialty certification. Eligible pharmacists will be able to sit for the first BPS CSP pharmacy certification examination in the fall of 2019.
“According to the U.S. Pharmacopeia (USP), millions of medications are compounded each year to meet the unique needs of patients,” explained BPS Executive Director, William M. Ellis, MS, RPh. “The public reports of patient illness and even deaths due to improperly prepared sterile compounded preparations only underscore the need to create a process to independently validate the knowledge and skills of those pharmacists working in this important practice area.
“As healthcare providers, hospitals and other healthcare institutions are becoming increasingly accountable for the quality of the care delivered to patients, approving the CSP Pharmacy Specialty represents our commitment to developing a process to help assure that quality,” Ellis added.
“The ultimate goals of specialization are to ensure quality patient care and improve therapeutic outcomes,” said UC Davis Medical Center Oncology and Investigational Drugs Services Assistant Chief Pharmacist, Andrea Iannucci, PharmD, BCOP, who also serves as the 2018 Chair of the BPS Board of Directors. “We are confident the BPS CSP Pharmacy Specialty will achieve those goals by making it clear to employers, third-party payers, physicians and patients that those pharmacists have demonstrated specialized competencies and expertise in sterile compounding.”
“Creating a mechanism for pharmacists to distinguish themselves as experts in sterile compounding also will enable healthcare providers to prescribe and order compounded medications from pharmacies and outsourcing facilities with a BPS Board Certified Sterile Compounding Pharmacist on staff,” added Elizabeth Jungman, MPh, JD, Director of Public Health Programs at The Pew Charitable Trusts.
ABOUT THE BOARD OF PHARMACY SPECIALTIES
Established in 1976 as an autonomous division of the American Pharmacists Association (APhA), the mission of the Board of Pharmacy Specialties (BPS) is to improve patient care and outcomes and generate awareness of the vital role BPS Board Certified Pharmacists play as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills.
Today, there are more than 36,000 uniquely trained and educated BPS board certified pharmacists in the U.S. and 26 countries. As a result of the rigorous standards mandated by BPS, board certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels.
Social Media & Content Marketing Manager